Provided by Tiger Trade Technology Pte. Ltd.

Merck

121.93
+2.181.82%
Post-market: 121.56-0.3700-0.30%19:46 EST
Volume:13.08M
Turnover:1.59B
Market Cap:302.63B
PE:16.75
High:122.66
Open:120.76
Low:120.44
Close:119.75
52wk High:122.66
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.60
T/O Rate:0.53%
Dividend:3.28
Dividend Rate:2.69%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:37.17%
ROA:13.76%
PB:5.84
PE(LYR):16.75

Loading ...

Delta, Merck, Caterpillar, CoreWeave, Enphase: Insider Shockwave

TIPRANKS
·
Yesterday

Enphase, Cloudflare, Merck, Microsoft, fuboTV Trending Among Analysts

TIPRANKS
·
Yesterday

Wave of Insider Moves as Merck’s Top Brass Cash In on Company Stock

TIPRANKS
·
Yesterday

Merck EVP and Chief Information & Digital Officer David Michael Williams Reports Disposal of Common Shares

Reuters
·
Yesterday

Merck SVP Finance Dalton E. Smart III Reports Disposal of Common Shares

Reuters
·
Yesterday

Johannes Jacobus Oosthuizen, President U.S. Market, Reports Disposal of Merck & Co. Inc. Common Shares

Reuters
·
Yesterday

Merck Executive VP Dean Y. Li Sells Common Shares

Reuters
·
Yesterday

Merck & Co. Chief Marketing Officer Chirfi Guindo Reports Sale of Common Shares

Reuters
·
Yesterday

Merck EVP and Animal Health President Richard R. DeLuca Reports Disposal of Common Shares

Reuters
·
Yesterday

Merck Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 06

Guggenheim Adjusts Price Target on Merck & Co to $140 From $122, Maintains Buy Rating

MT Newswires Live
·
Feb 06

Zoom, Kinsale Capital, Palantir And A Health Care Stock On CNBC's 'Final Trades'

Benzinga_recent_news
·
Feb 06

Guggenheim Sticks to Their Buy Rating for Merck & Company (MRK)

TIPRANKS
·
Feb 06

Merck & Co. Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 06

Health Rounds: Women who have had an HPV vaccine need fewer cervical cancer screenings

Reuters
·
Feb 06

Merck Says Health Canada Approves Enflonsia for Respiratory Syncytial Virus Prevention in Newborns, Infants

MT Newswires Live
·
Feb 06

Merck Announces Health Canada Approval of Enflonsia® for the Prevention of Rsv in Newborns and Infants

THOMSON REUTERS
·
Feb 05

Merck (MRK) Margin Surge And 56.7% Earnings Growth Challenge Cautious Growth Narratives

Simply Wall St.
·
Feb 05

Merck's Pipeline Progress and Business Development Strategy Remain in Focus, Morgan Stanley Says

MT Newswires Live
·
Feb 04

Merck Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Feb 04